English High Court affirms the validity of Eli Lilly’s ADHD patent

18-11-2015

English High Court affirms the validity of Eli Lilly’s ADHD patent

Take Photo / Shutterstock.com

The English High Court has affirmed the validity of Eli Lilly’s European patent covering the use of the drug Strattera (atomoxetine), used to treat attention-deficit hyperactivity disorder (ADHD).


English High Court; ADHD; Eli Lilly; ADHD; generics; SPCs

LSIPR